CHEMCON

🏷️ Company Overview & Business Focus

🏷️ Company Overview & Business Focus Chemcon manufactures specialty chemicals like HMDS (Hexamethyldisilazane), CMIC, and inorganic bromides (calcium bromide, zinc bromide, sodium bromide). These chemicals have applications in pharmaceuticals, oilfield chemicals, and more. It is based in Gujarat, India, with operations in multiple small plants (nine operational plants mentioned) and in-house R&D capabilities. It has a relatively low debt burden (debt-to-equity ~0.05) and moderate margins (~11–12% net margin) per recent data. Over the past few years, its long-term sales growth has been weak: over 5 years sales growth has been negative (~ –4.5%). 📈 Market & Valuation The stock’s current price is ~ ₹266 / ₹267 (on NSE) with a 52-week range from ~ ₹160 to ₹295. Valuation: P/E is high (in high 30s) and PB ~2x. The high P/E suggests the market is pricing in a turnaround or growth hopes. The company has generally not paid meaningful dividends (dividend yield is close to 0%). Return on equity (ROE) in recent years has been modest (single-digit) — not very strong for a specialty chemicals player. Some analysis notes that while short-term earnings growth was strong (e.g. a jump in EPS last year), over a 3-year horizon cumulative EPS has declined strongly. In other words, volatility in performance is a risk.